effect
sever
acut
respiratori
syndrom
sar
vaccin
like
includ
compon
induc
specif
cytotox
tlymphocyt
ctl
respons
specif
respons
govern
human
leukocyt
antigen
hla
restrict
present
sarsderiv
peptid
epitop
exact
knowledg
immun
system
handl
protein
antigen
would
allow
identif
linear
sequenc
directli
genomicproteom
sequenc
inform
lauemol
et
al
rev
immunogenet
latter
recent
establish
caus
coronaviru
sarscov
isol
fulllength
sequenc
marra
et
al
scienc
combin
advanc
bioinformat
highthroughput
immunolog
perform
hla
supertyp
genomewid
scan
sarsspecif
ctl
epitop
scan
includ
nine
human
hla
supertyp
total
cover
individu
major
human
popul
sett
sidney
immunogenet
hla
supertyp
select
top
candid
test
biochem
bind
assay
time
approxim
month
genom
establish
test
major
hla
supertyp
identifi
almost
potenti
vaccin
candid
valid
sar
survivor
use
vaccin
formul
suggest
immunobioinformat
may
becom
fast
valuabl
tool
ration
vaccin
design
sever
acut
respiratori
syndrom
sar
month
infect
patient
countri
caus
death
prospect
deadli
epidem
signific
disrupt
consequ
mani
health
social
econom
polit
aspect
life
coordin
classic
measur
includ
case
detect
isol
infect
control
contact
trace
followup
surveil
success
contain
diseas
howev
diseas
proven
resili
exclud
resurfac
given
right
condit
occur
even
best
health
system
would
sever
strain
resum
sustain
contain
effort
implement
spring
ideal
sarscoronaviru
sarscov
erad
would
requir
detect
assay
track
diseas
intervent
measur
break
chain
transmiss
procedur
simpl
yet
effect
unfortun
diagnost
test
current
avail
control
transmiss
contain
sole
complic
extrem
costli
complic
erad
effort
nonhuman
reservoir
appear
exist
thu
strong
case
sar
vaccin
made
would
signific
help
erad
effort
fail
could
protect
infect
individu
diseas
sarscov
infect
epitheli
cell
respiratori
tract
caus
interstiti
pneumonia
one
would
therefor
expect
effect
vaccin
induc
mucos
immun
effect
secretori
immunoglobulin
iga
specif
prevent
infecti
agent
penetr
mucos
epithelium
cytotox
lymphocyt
ctl
specif
erad
infect
cell
iga
respons
gener
consid
major
protect
mechan
howev
exampl
ctl
antibodi
respons
earli
control
mucos
infect
particularli
noteworthi
case
infecti
bronchiti
viru
chick
prototyp
coronavirida
famili
primari
effector
ctl
play
critic
role
elimin
viru
acut
infect
subsequ
control
infect
human
ctl
specif
peptid
present
context
human
leukocyt
antigen
hla
molecul
gener
known
major
histocompat
complex
mhc
molecul
prior
present
peptid
gener
cytosol
limit
proteolyt
fragment
avail
protein
antigen
transloc
endoplasm
reticulum
specif
sampl
mhc
molecul
export
cell
surfac
await
ctl
scrutini
importantli
hla
extrem
polymorph
peptid
bind
specif
vari
differ
polymorph
hla
molecul
howev
suggest
major
major
human
popul
cover
three
nine
hla
supertyp
differ
member
supertyp
bind
similar
peptid
one
knew
exactli
peptid
gener
select
genomicproteom
inform
could
use
predict
outcom
antigen
present
forecast
immunogen
use
advanc
immunobioinformat
tool
mimic
antigen
present
highli
costand
timeeffect
manner
predict
possibl
immunogen
epitop
complet
sar
genomeproteom
obtain
genbank
virtual
digest
uniqu
nonam
peptid
thu
close
bind
predict
made
nine
hla
supertyp
artifici
neural
network
ann
use
predict
bind
affin
quantit
correspond
data
avail
eg
perform
ann
high
correl
coeffici
predict
measur
bind
remain
hla
bind
predict
use
weight
matric
deriv
gibb
sampl
sequenceweight
method
pseudocount
correct
low
count
well
differenti
positionspecif
anchor
weight
nielsen
et
al
manuscript
prepar
weight
matric
calcul
avail
nonam
data
syfpeithi
mhcpep
databas
peptid
cluster
nine
supertyp
posit
predict
valu
matrixdriven
predict
found
around
wherea
neg
predict
valu
found
around
lamberth
et
al
unpublish
observ
proteasom
process
predict
use
netchop
netchop
found
superior
proteasom
predict
algorithm
peptid
netchop
score
ie
poorli
predict
proteasom
process
exclud
analysi
final
exclud
peptid
repres
epitop
conserv
sar
isol
figur
show
repres
exampl
member
supertyp
hlaa
haplotyp
particularli
common
southeast
asia
hla
supertyp
toprank
nonam
peptid
synthes
standard
fmoc
chemistri
purifi
reversedphas
highperform
liquid
chromatographi
least
usual
puriti
valid
mass
spectrometri
interact
epitop
candid
appropri
hla
subsequ
valid
biochem
bind
assay
briefli
denatur
purifi
recombin
hla
heavi
chain
dilut
renatur
buffer
contain
hla
light
chain
b
microglobulin
grade
concentr
peptid
test
incub
c
h
allow
equilibrium
reach
previous
demonstr
denatur
hla
molecul
de
novo
fold
effici
howev
presenc
appropri
peptid
concentr
peptidehla
complex
gener
measur
quantit
enzymelink
immunosorb
assay
plot
concentr
peptid
offer
fig
effect
concentr
hla
nm
use
assay
equilibrium
dissoci
constant
k
highaffin
peptidehla
interact
peptid
concentr
lead
halfsatur
hla
reason
approxim
affin
interact
initi
screen
procedur
employ
wherebi
singl
high
concentr
nm
peptid
incub
one
hla
molecul
complex
format
found
peptid
assign
nonbind
hla
molecul
question
convers
complex
format
found
initi
screen
full
titrat
peptid
perform
determin
affin
bind
result
bind
isotherm
analyz
onesit
hyperbola
regress
prism
graphpad
determin
concentr
hla
employ
nm
data
shown
k
interact
tabl
good
curv
fit
r
alway
major
case
data
shown
gener
intermedi
highaffin
binder
k
better
ie
lower
nm
nm
respect
higher
affin
like
peptid
go
tcell
epitop
tabl
summar
data
hlaa
hlaa
pep
toprank
peptid
combin
involv
crossrespons
peptid
predict
toprank
binder
one
hla
molecul
turn
binder
member
anoth
hla
supertyp
ie
support
content
hla
supertyp
effect
signific
diversif
antisar
ctl
respons
convers
overlap
differ
member
hla
supertyp
appear
extens
thu
peptid
predict
good
binder
found
bind
anoth
member
supertyp
hlaa
similarli
nine
peptid
predict
good
binder
found
bind
hlaa
tabl
nine
supertyp
test
would
project
found
well
differ
vaccin
candid
would
predict
success
process
proteasom
biochem
valid
hla
bind
therefor
high
probabl
peptid
inde
present
ctl
occur
approxim
chanc
abl
rais
ctl
respons
thu
data
likelihood
includ
ctl
epitop
identifi
bind
peptid
one
could
search
correspond
ctl
reactiv
peripher
blood
sar
survivor
use
robust
reason
simpl
technolog
interferong
secret
stimul
whole
blood
cell
peptid
binder
hlaa
top
frame
hlaa
bottom
frame
sort
accord
predict
bind
strength
synthes
affin
bind
determin
peptid
sequenc
given
singlelett
code
measur
bind
affin
given
kd
near
futur
genom
pathogen
fulli
sequenc
matter
day
bioinformat
tool
current
develop
perfect
abl
use
genom
inform
predict
immun
epitop
comput
correspond
immunolog
tool
current
abl
valid
predict
matter
week
month
predict
epitop
identif
near
futur
fast
dna
sequenc
handl
whole
organ
dissemin
tool
one
could
envis
clinician
scientist
anywher
would
abl
analyz
pathogen
interest
agent
bioterror
tumor
cell
purpos
fast
identif
immunogen
epitop
timelin
present
sar
epidem
demonstr
fast
modern
scienc
identifi
pathogen
deciph
genom
use
inform
fast
ration
design
vaccin
immunobioinformat
promis
take
develop
one
step
